Novartis
NVS
NVS
1,132 hedge funds and large institutions have $26.2B invested in Novartis in 2019 Q1 according to their latest regulatory filings, with 114 funds opening new positions, 419 increasing their positions, 396 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,132
Holders Change
+46
Holders Change %
+4.24%
% of All Funds
24.54%
Holding in Top 10
39
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-2.5%
% of All Funds
0.85%
New
114
Increased
419
Reduced
396
Closed
56
Calls
$146M
Puts
$94.9M
Net Calls
+$50.8M
Net Calls Change
+$23.4M
Top Buyers
Top Sellers
1 |
BlackRock
New York
|
-$124M |
2 |
Capital International Investors
Los Angeles,
California
|
-$64.7M |
3 |
D.E. Shaw & Co
New York
|
-$60.6M |
4 |
Boston Partners
Boston,
Massachusetts
|
-$56.2M |
5 |
MAM
Majedie Asset Management
London,
United Kingdom
|
-$56M |